Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence-Assisted Evaluation of Pulmonary Hypertension

NCT05566002 is registered in ClinicalTrials.gov with Chinese Pulmonary Vascular Disease Research Group as lead sponsor.

NCT NCT05566002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05566002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence-Assisted Evaluation of Pulmonary Hypertension
Lead sponsor
Chinese Pulmonary Vascular Disease Research Group
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2022
Completion date
December 31, 2025
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, pulmonary hypertension